TQB2252 Injection

TQB2252 · Chia Tai Tianqing Pharmaceutical (Guangzhou) Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB2252 Injection, covering 2024-10-21 to 2024-10-21. Get the full timeline:

Most recent: Clinical Trial Update: A Multicenter, Open Label Phase I Clinical Trial Evaluating the Safety and Pharmacokinetics of TQB2252 Injection in Subjects With Advanced Malignant Tumors [Phase 1]

See pricing